STOMP: Small cell lung cancer trial of olaparib (AZD2281) as maintenance programme - a randomised, double blind, multicentre NCRN phase II trial

被引：0
|
作者：
Woll, P. J. [1 ]
Jarrett, H. [2 ]
Billingham, L. [2 ]
机构：
[1] Univ Sheffield, Weston Pk Hosp, Sheffield S10 2TN, S Yorkshire, England
[2] Univ Birmingham, CRUK Clin Trials Unit, Birmingham B15 2TT, W Midlands, England
来源：
LUNG CANCER | 2011年 / 71卷
关键词：
D O I：
10.1016/S0169-5002(11)70121-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
121
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [41] Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer
    PJ Woll
    R Basser
    T Le Chevalier
    P Drings
    G Perez Manga
    A Adenis
    L Seymour
    F Smith
    N Thatcher
    British Journal of Cancer, 1997, 76 : 264 - 265
  • [42] A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer
    Gatzemeier, U
    Manegold, C
    Eberhard, W
    Wilke, HJ
    Chomy, F
    Chomy, P
    Khayat, D
    Blatter, J
    Seeber, S
    Drings, P
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 836 - 838
  • [43] PHASE-II TRIAL OF EDATREXATE IN SMALL-CELL LUNG-CANCER
    WIESENFELD, A
    JETT, JR
    SU, JQ
    BRAICH, TA
    KARDINAL, CG
    MAILLIARD, JA
    VEEDER, MH
    MORTON, RF
    MICHALAK, JC
    CANCER, 1994, 73 (04) : 1189 - 1193
  • [44] A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion
    Ahmedzai, SH
    Laude, E
    Robertson, A
    Troy, G
    Vora, V
    BRITISH JOURNAL OF CANCER, 2004, 90 (02) : 366 - 371
  • [45] A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion
    S H Ahmedzai
    E Laude
    A Robertson
    G Troy
    V Vora
    British Journal of Cancer, 2004, 90 : 366 - 371
  • [46] A Randomised Phase II Trial of Vitamin C Synergy with Hyperthermia in Patients with Advanced Non-Small-Cell Lung Cancer
    Ou, J.
    Zhu, X.
    Chen, P.
    Du, Y.
    Lu, Y.
    Peng, X.
    Bao, S.
    Wang, J.
    Zhang, X.
    Zhang, T.
    Pang, C. L. K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S926 - S927
  • [47] The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer
    van Elmpt, Wouter
    De Ruysscher, Dirk
    van der Salm, Anke
    Lakeman, Annemarie
    van der Stoep, Judith
    Emans, Daisy
    Damen, Eugene
    Ollers, Michel
    Sonke, Jan-Jakob
    Belderbos, Jose
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 67 - 71
  • [48] BR31: A phase 3, double blind, placebo controlled, randomised trial of adjuvant durvalumab in completely resected non-small cell lung cancer
    McLachlan, Sue-Anne
    Mersiades, Antony
    Wright, Gavin
    Millward, Michael
    Goss, Glenwood
    Darling, Gail
    Jurkovic, Hannora
    Bradley, Ann-Marie
    Pavlakis, Nick
    Blinman, Prunella
    Ding, Keyue
    O'Callaghan, Chris
    Stockler, Martin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 198 - 199
  • [49] Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer
    Liu, Yue-E
    Xue, Xiao-Ying
    Zhang, Rui
    Chen, Xue-Ji
    Ding, Yu-Xia
    Liu, Chao-Xing
    Qin, Yue-Liang
    Li, Wei-Qian
    Ren, Xiao-Cang
    Lin, Qiang
    BMJ OPEN, 2020, 10 (10):
  • [50] Experiences of pre-trial quality assurance (QA) for the CONVERT trial. A multicentre randomised phase III trial for good performance status patients with limited stage small cell lung cancer
    Wilson, E.
    Groom, N.
    Lyn, E.
    Miles, E.
    Tsang, Y.
    Faivre-Finn, C.
    LUNG CANCER, 2012, 75 : S55 - S56
12345